(COP) CompuGroup Medical SE & Co. - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A288904
COP: Ambulatory, Hospital, Pharmacy, Software,
CompuGroup Medical SE & Co. KGaA is a leading provider of e-health solutions, operating across Germany, Western and Eastern Europe, North America, and international markets. The company is structured into three core business segments: Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS). The AIS segment specializes in software solutions for outpatient care, catering to physicians, medical care centers, and physician networks. It offers comprehensive clinical, administrative, and billing management tools, along with secure data exchange platforms for healthcare professionals and patients. Additionally, this segment provides data-driven products, medical decision support tools, and digital applications designed to enhance efficiency and patient outcomes.
The Hospital Information Systems (HIS) segment delivers integrated clinical and administrative solutions for inpatient care settings, including acute care hospitals, rehabilitation centers, and radiology networks. Its offerings encompass patient administration, resource management, medical documentation, billing, and financial control systems. The segment also provides specialized clinical applications for departments such as laboratories and radiology, ensuring streamlined workflows and improved care delivery.
The Pharmacy Information Systems (PCS) segment focuses on providing software solutions for pharmacies, supporting the entire medication supply chain. This includes inventory management, procurement, shipping, and retail operations. The segment’s applications are designed to optimize operational efficiency and ensure compliance with regulatory requirements, making it a critical partner for pharmacies in managing their core business processes.
Founded in 1987 and headquartered in Koblenz, Germany, CompuGroup Medical SE & Co. KGaA has established itself as a key player in the healthcare IT sector, with a strong emphasis on innovation and customer-centric solutions. Its software applications are widely used across the healthcare continuum, facilitating better coordination and delivery of medical services.
Exchange: XETRA
Type: common stock
Country Origin: Germany
GICS Sub Industry: Health Care Technology
Web URL: https://www.cgm.com
Forecast: Based on the provided data, CompuGroup Medical SE & Co. KGaA (XETRA:COP) is trading near its 20-day SMA (22.12) and slightly below its 50-day SMA (22.39), indicating a neutral short-term trend. The stock’s price of 22.16 reflects a stable position relative to its recent moving averages. The low ATR (0.24) suggests minimal volatility, while the SMA 200 (18.39) indicates upside potential over the longer term. From a fundamental perspective, the company’s P/E ratio (33.55) signals a premium valuation, reflecting market expectations for growth. However, the P/S ratio (0.97) and RoE (5.34%) suggest moderate profitability relative to its revenue and equity. Overall, the stock may experience consolidation in the short term, with upside driven by its growth prospects in the e-health sector.
Additional Sources for COP Stock
COP Stock Overview
Market Cap in USD | 1,294m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
COP Stock Ratings
Growth Rating | -67.8 |
Fundamental | 7.51 |
Dividend Rating | 43.5 |
Rel. Strength | -19.3 |
Analysts | - |
Fair Price Momentum | 18.70 EUR |
Fair Price DCF | 27.23 EUR |
COP Dividends
Dividend Yield 12m | 4.77% |
Yield on Cost 5y | 1.63% |
Annual Growth 5y | 14.87% |
Payout Consistency | 62.0% |
COP Growth Ratios
Growth Correlation 3m | -71.3% |
Growth Correlation 12m | -4.9% |
Growth Correlation 5y | -92% |
CAGR 5y | -18.93% |
CAGR/Max DD 5y | -0.23 |
Sharpe Ratio 12m | -0.08 |
Alpha | -28.34 |
Beta | 0.312 |
Volatility | 30.72% |
Current Volume | 38.3k |
Average Volume 20d | 37.4k |
As of May 05, 2025, the stock is trading at EUR 22.16 with a total of 38,276 shares traded.
Over the past week, the price has changed by +0.09%, over one month by +0.27%, over three months by -2.98% and over the past year by -19.70%.
Neither. Based on ValueRay Fundamental Analyses, CompuGroup Medical SE & Co. is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.51 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COP as of May 2025 is 18.70. This means that COP is currently overvalued and has a potential downside of -15.61%.
CompuGroup Medical SE & Co. has no consensus analysts rating.
According to ValueRays Forecast Model, COP CompuGroup Medical SE & Co. will be worth about 20.2 in May 2026. The stock is currently trading at 22.16. This means that the stock has a potential downside of -8.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 21.3 | -4% |
Analysts Target Price | - | - |
ValueRay Target Price | 20.2 | -8.8% |